FAK inhibition induces glioblastoma cell senescence-like state through p62 and p27

Author

Alza, Lía

Nàger Grifo, Mireia

Visa Pretel, Anna

Cantí Nicolás, Carles

Herreros Danés, Judit

Publication date

2020-06-02T10:35:09Z

2020-06-02T10:35:09Z

2020-04-27

2020-06-02T10:35:09Z



Abstract

Focal adhesion kinase (FAK) is a central component of focal adhesions that regulate cancer cell proliferation and migration. Here, we studied the effects of FAK inhibition in glioblastoma (GBM), a fast growing brain tumor that has a poor prognosis. Treating GBM cells with the FAK inhibitor PF-573228 induced a proliferative arrest and increased cell size. PF-573228 also reduced the growth of GBM neurospheres. These effects were associated with increased p27/CDKN1B levels and β-galactosidase activity, compatible with acquisition of senescence. Interestingly, FAK inhibition repressed the expression of the autophagy cargo receptor p62/SQSTM-1. Moreover, depleting p62 in GBM cells also induced a senescent-like phenotype through transcriptional upregulation of p27. Our results indicate that FAK inhibition arrests GBM cell proliferation, resulting in cell senescence, and pinpoint p62 as being key to this process. These findings highlight the possible therapeutic value of targeting FAK in GBM.


This research was funded by Spanish Ministry of Science & Innovation (“Retos” Program), grant number RTI2018-094739-B-I00 to JH and CC. The APC was funded by Spanish Ministry of Science & Innovation

Document Type

Article
Published version

Language

English

Subjects and keywords

FAK; Glioblastoma; Proliferation; p62/SQSTM-1; p27/CDKN1B

Publisher

MDPI

Related items

info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-094739-B-I00/ES/NUEVOS MECANISMOS DE DESREGULACION DE LA SEÑALIZACION POR CALCIO CONTRA EL GLIOBLASTOMA/

Reproducció del document publicat a https://doi.org/10.3390/cancers12051086

Cancers, 2020, vol. 12, núm. 5, p. E1086

Rights

cc by (c) Alza et al., 2020

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)